Clinical Trial Update: Biomarkers for Clinical Classification and Outcomes of Immune Checkpoint Inhibitor-Related-Related Myocarditis in Lung Cancer

View source ↗

Summary

This clinical trial focuses on biomarkers to classify immune checkpoint inhibitor–related myocarditis and predict outcomes in patients with lung cancer. The stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer
• Myocarditis

Snippet

Sponsor: Shanghai Chest Hospital | Conditions: Lung Cancer, Myocarditis Due to Drug | Status: RECRUITING